Your browser doesn't support javascript.
loading
Assessment of the adverse effects of sirolimus versus everolimus in pediatric heart transplant recipients.
Newland, David M; Rosete, Beatrice E; Law, Yuk M; Kemna, Mariska S; Albers, Erin L; Hong, Borah J; Ahmed, Humera; Spencer, Kathryn L; Friedland-Little, Joshua M.
  • Newland DM; Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington, USA.
  • Rosete BE; School of Pharmacy, University of Washington, Seattle, Washington, USA.
  • Law YM; Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington, USA.
  • Kemna MS; School of Pharmacy, University of Washington, Seattle, Washington, USA.
  • Albers EL; Division of Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA.
  • Hong BJ; Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA.
  • Ahmed H; Division of Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA.
  • Spencer KL; Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA.
  • Friedland-Little JM; Division of Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA.
Pediatr Transplant ; 27(3): e14487, 2023 05.
Article en En | MEDLINE | ID: mdl-36869621

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Corazón / Sirolimus Tipo de estudio: Observational_studies Límite: Child / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Corazón / Sirolimus Tipo de estudio: Observational_studies Límite: Child / Humans Idioma: En Año: 2023 Tipo del documento: Article